STIM (Neuronetics) Other Gross PPE: $26.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STIM Neuronetics Inc STIM
57 GF Score
Price $2.97
GF Value $1.78
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Neuronetics Other Gross PPE?

Neuronetics STIM -0.84% 57 Other Gross PPE is $26.0 Mil as of Jun. 2026. GuruFocus rates STIM with a GF Score™ of 57/100 and a GF Value™ of $1.78 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Neuronetics's Other Gross PPE for the quarter that ended in Jun. 2026 was $26.0 Mil.

Neuronetics's quarterly Other Gross PPE declined from Dec. 2025 ($30.7 Mil) to Mar. 2026 ($25.6 Mil) but then increased from Mar. 2026 ($25.6 Mil) to Jun. 2026 ($26.0 Mil).

Neuronetics's annual Other Gross PPE increased from Dec. 2023 ($6.0 Mil) to Dec. 2024 ($35.3 Mil) but then declined from Dec. 2024 ($35.3 Mil) to Dec. 2025 ($30.7 Mil).

Neuronetics Other Gross PPE Historical Data

* Premium members only.

The historical data trend for Neuronetics's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neuronetics Other Gross PPE Chart

Neuronetics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.55 6.11 6.00 35.26 30.69

Neuronetics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.19 31.73 30.69 25.57 25.99
STIM
57GF Score
Neuronetics Inc STIM
Other Gross PPE is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Neuronetics Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Frequently Asked Questions Learn more about Other Gross PPE →
What does a Other Gross PPE of $26.0 Mil mean?
Neuronetics (STIM) has a Other Gross PPE of $26.0 Mil as of Jun. 2026. Other Gross PPE is property, plant and equipment recorded on a company's balance sheet that not otherwise classified. View historical data on Neuronetics and its competitors.
Is Neuronetics' Other Gross PPE too high?
Neuronetics' current Other Gross PPE is $26.0 Mil. Overall, Neuronetics has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Neuronetics' Other Gross PPE compare to MXCT and CVRX?
Neuronetics' Other Gross PPE of $26.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Gross PPE for a Medical Devices & Instruments company?
A good Other Gross PPE depends on the Medical Devices & Instruments industry context. However, Other Gross PPE should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Gross PPE mean?
A high Other Gross PPE can signal that a stock is expensive relative to its fundamentals. Other Gross PPE is property, plant and equipment recorded on a company's balance sheet that not otherwise classified. View historical data on Neuronetics and its competitors. Neuronetics's current Other Gross PPE is $26.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neuronetics stock overvalued right now?
Based on GuruFocus' analysis, Neuronetics (STIM) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.78, compared to a current price of $2.97 — trading 66.9% above its estimated fair value. The current Other Gross PPE is $26.0 Mil. Neuronetics' overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Gross PPE calculated?
Other Gross PPE is calculated from a company's financial statements. For Neuronetics (STIM), the current Other Gross PPE is $26.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Neuronetics (STIM) Overvalued in 2026?

Based on GuruFocus' analysis, Neuronetics stock appears to be overvalued. The current stock price of $2.97 is trading 66.9% above its estimated GF Value™ of $1.78. GuruFocus considers Neuronetics to be Significantly Overvalued.

Key valuation signals for STIM:

  • Other Gross PPE: $26.0 Mil
  • GF Value™: $1.78 vs. price of $2.97 (66.9% above fair value)
  • GF Score™: 57/100 with 5 warning signs

No single metric tells the full story. See the STIM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Neuronetics Business Description

Other Exchanges NRC:Germany
Address 3222 Phoenixville Pike, Malvern, PA, USA, 19355
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.
57GF Score

Get the complete analysis for STIM

Other Gross PPE is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.97
Price
$1.78
GF Value